Skip to main content
Top
Published in: Archives of Osteoporosis 1/2020

01-12-2020 | Osteoporosis | Original Article

Associations between bone mineral density and coronary artery disease: a meta-analysis of cross-sectional studies

Authors: Yonghui Zhang, Bing He, Haijiao Wang, Jianwei Shi, Hao Liang

Published in: Archives of Osteoporosis | Issue 1/2020

Login to get access

Abstract

Summary

A meta-analysis was performed to explore the association of coronary artery disease (CAD) with bone mineral density (BMD). Low BMD was not found to be associated with prevalence of CAD. Though the BMD of CADs is significantly lower than that of non-CADs, the confounding effect of aging could not be excluded as CADs might be more prevalent in older patients.

Purpose/introduction

The clinical association of coronary artery disease (CAD) with bone mineral density (BMD) has been increasingly reported, but findings on the relationship between the two age-related processes are conflicting. The aim of our study was to conduct a meta-analysis to evaluate the associations between CAD and BMD.

Methods

We searched PubMed, Embase, and Cochrane Library. Odds ratio (OR) and 95% confidence interval (CI) were pooled to assess the association between low BMD and the prevalence of CAD. For continuous data, standardized mean difference (SMD) with its 95% CI was pooled. Correlation coefficients of BMD and Gensini score were pooled after being transformed by Fischer z-transformation. Subgroup and meta-regression analyses were performed to explore the sources of heterogeneity.

Results

The meta-analysis involved 4170 participants from 11 studies. Pooled ORs for the incidence of CAD in patients with low BMD versus patients with normal BMD was 1.58 (95% CI 0.99–2.52, P = 0.06), and no statistical difference was found in men and women subgroups. After confounding age, the combined OR was 1.60 (95% OR 0.69–3.72, P = 0.27). Pooling data for comparing BMD of CADs and non-CADs were − 0.28 (95% CI − 0.47 to − 0.09, P = 0.004) in femoral neck and calcaneus, − 0.42 (95% CI − 0.89–0.05, P = 0.08) in lumbar spine, and − 0.25 (95% CI − 0.40 to − 0.11, P = 0.000) in the overall. A significance was detected in pooled correlation analysis between CAG Gensini score and BMD (COR = − 0.4435 [− 0.6647; − 0.1508], P = 0.004). No sources of heterogeneity were acquired, and no publication bias was identified.

Conclusions

Low BMD was not associated with the prevalence of CAD. Without age adjustment, the BMD of CADs is significantly lower than that of non-CADs, and the patients with lower BMD are inclined to more severe coronary artery lesions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ma L, Wu Y, Wang W, Chen W (2018) Interpretation of the report on cardiovascular diseases in China (2017). Chin J Cardiovasc Med 23:3–6 Ma L, Wu Y, Wang W, Chen W (2018) Interpretation of the report on cardiovascular diseases in China (2017). Chin J Cardiovasc Med 23:3–6
2.
go back to reference Hauger AV, Bergland A, Holvik K, Ståhle A, Emaus N, Strand BH (2018) Osteoporosis and osteopenia in the distal forearm predict all-cause mortality independent of grip strength: 22-year follow-up in the population-based Tromsø study. Osteoporos Int 29(11):2447–2456CrossRef Hauger AV, Bergland A, Holvik K, Ståhle A, Emaus N, Strand BH (2018) Osteoporosis and osteopenia in the distal forearm predict all-cause mortality independent of grip strength: 22-year follow-up in the population-based Tromsø study. Osteoporos Int 29(11):2447–2456CrossRef
3.
go back to reference Leboime A, Confavreux CB, Mehsen N, Paccou J, David C, Roux C (2010) Osteoporosis and mortality. Joint Bone Spine 77:S107–S112CrossRef Leboime A, Confavreux CB, Mehsen N, Paccou J, David C, Roux C (2010) Osteoporosis and mortality. Joint Bone Spine 77:S107–S112CrossRef
4.
go back to reference Stambler I, Jin K, Lederman S, Barzilai N, Olshansky SJ, Omokaro E, Barratt J, Anisimov VN, Rattan S, Yang S (2018) Aging health and R&D for healthy longevity must be included into the WHO work program. Aging Dis 9(2):331–333CrossRef Stambler I, Jin K, Lederman S, Barzilai N, Olshansky SJ, Omokaro E, Barratt J, Anisimov VN, Rattan S, Yang S (2018) Aging health and R&D for healthy longevity must be included into the WHO work program. Aging Dis 9(2):331–333CrossRef
5.
go back to reference Laroche M, Pécourneau V, Blain H, Breuil V, Chapurlat R, Cortet B, Sutter B, Degboe Y (2017) Osteoporosis and ischemic cardiovascular disease. Joint Bone Spine 84(4):427–432CrossRef Laroche M, Pécourneau V, Blain H, Breuil V, Chapurlat R, Cortet B, Sutter B, Degboe Y (2017) Osteoporosis and ischemic cardiovascular disease. Joint Bone Spine 84(4):427–432CrossRef
6.
go back to reference Szekanecz Z, Kerekes G, Kardos Z, Baráth Z, Tamási L (2016) Mechanisms of inflammatory atherosclerosis in rheumatoid arthritis. Curr Immunol Rev 12(1):35–46CrossRef Szekanecz Z, Kerekes G, Kardos Z, Baráth Z, Tamási L (2016) Mechanisms of inflammatory atherosclerosis in rheumatoid arthritis. Curr Immunol Rev 12(1):35–46CrossRef
7.
go back to reference Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22(7):2465–2475CrossRef Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22(7):2465–2475CrossRef
8.
go back to reference Sage AP, Lu J, Atti E, Tetradis S, Ascenzi MG, Adams DJ, Demer LL, Tintut Y (2011) Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids. J Bone Miner Res 26(6):1197–1206CrossRef Sage AP, Lu J, Atti E, Tetradis S, Ascenzi MG, Adams DJ, Demer LL, Tintut Y (2011) Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids. J Bone Miner Res 26(6):1197–1206CrossRef
9.
go back to reference Tarakida A, Iino K, Abe K, Taniguchi R, Higuchi T, Mizunuma H, Nakaji S (2011) Hypercholesterolemia accelerates bone loss in postmenopausal women. Climacteric 14(1):105–111CrossRef Tarakida A, Iino K, Abe K, Taniguchi R, Higuchi T, Mizunuma H, Nakaji S (2011) Hypercholesterolemia accelerates bone loss in postmenopausal women. Climacteric 14(1):105–111CrossRef
10.
go back to reference Lampropoulos CE, Papaioannou I, D’cruz DP (2012) Osteoporosis—a risk factor for cardiovascular disease? Nat Rev Rheumatol 8(10):587–598CrossRef Lampropoulos CE, Papaioannou I, D’cruz DP (2012) Osteoporosis—a risk factor for cardiovascular disease? Nat Rev Rheumatol 8(10):587–598CrossRef
11.
go back to reference Varma R, Aronow WS, Basis Y, Singh T, Kalapatapu K, Weiss MB, Pucillo AL, Monsen CE (2008) Relation of bone mineral density to frequency of coronary heart disease. Am J Cardiol 101(8):1103–1104CrossRef Varma R, Aronow WS, Basis Y, Singh T, Kalapatapu K, Weiss MB, Pucillo AL, Monsen CE (2008) Relation of bone mineral density to frequency of coronary heart disease. Am J Cardiol 101(8):1103–1104CrossRef
12.
go back to reference Erbilen E, Yazici S, Özhan H, Bulur S, Ordu S, Yazici M (2007) Relationship between angiographically documented coronary artery disease and low bone mass in men. Circ J 71(7):1095–1098CrossRef Erbilen E, Yazici S, Özhan H, Bulur S, Ordu S, Yazici M (2007) Relationship between angiographically documented coronary artery disease and low bone mass in men. Circ J 71(7):1095–1098CrossRef
13.
go back to reference Sinnott B, Syed I, Sevrukov A, Barengolts E (2006) Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif Tissue Int 78(4):195–202CrossRef Sinnott B, Syed I, Sevrukov A, Barengolts E (2006) Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif Tissue Int 78(4):195–202CrossRef
14.
go back to reference Tekin GO, Kekilli E, Yagmur J, Uckan A, Yagmur C, Aksoy Y, Turhan H, Yetkin E (2008) Evaluation of cardiovascular risk factors and bone mineral density in post menopausal women undergoing coronary angiography. Int J Cardiol 131(1):66–69CrossRef Tekin GO, Kekilli E, Yagmur J, Uckan A, Yagmur C, Aksoy Y, Turhan H, Yetkin E (2008) Evaluation of cardiovascular risk factors and bone mineral density in post menopausal women undergoing coronary angiography. Int J Cardiol 131(1):66–69CrossRef
15.
go back to reference Ye C, Xu M, Wang S, Jiang S, Chen X, Zhou X, He R (2016) Decreased bone mineral density is an independent predictor for the development of atherosclerosis: a systematic review and meta-analysis. PLoS One 11(5):e0154740CrossRef Ye C, Xu M, Wang S, Jiang S, Chen X, Zhou X, He R (2016) Decreased bone mineral density is an independent predictor for the development of atherosclerosis: a systematic review and meta-analysis. PLoS One 11(5):e0154740CrossRef
16.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRef
17.
go back to reference Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRef Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRef
18.
go back to reference Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, Initiative S (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12(12):1495–1499CrossRef Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, Initiative S (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12(12):1495–1499CrossRef
19.
go back to reference Jüni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282(11):1054–1060CrossRef Jüni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282(11):1054–1060CrossRef
20.
go back to reference Marcovitz PA, Tran HH, Franklin BA, O’Neill WW, Yerkey M, Boura J, Kleerekoper M, Dickinson CZ (2005) Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96(8):1059–1063CrossRef Marcovitz PA, Tran HH, Franklin BA, O’Neill WW, Yerkey M, Boura J, Kleerekoper M, Dickinson CZ (2005) Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96(8):1059–1063CrossRef
21.
go back to reference Beer S, Saely C, Hoefle G, Rein P, Vonbank A, Breuss J, Gaensbacher B, Muendlein A, Drexel H (2010) Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men. Osteoporos Int 21(10):1695–1701CrossRef Beer S, Saely C, Hoefle G, Rein P, Vonbank A, Breuss J, Gaensbacher B, Muendlein A, Drexel H (2010) Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men. Osteoporos Int 21(10):1695–1701CrossRef
22.
go back to reference Hajsadeghi S, Khamseh M-E, Larijani B, Abedin B, Vakili-Zarch A, Meysamie A-P, Yazdanpanah F (2011) Bone mineral density and coronary atherosclerosis. J Saudi Heart Assoc 23(3):143–146CrossRef Hajsadeghi S, Khamseh M-E, Larijani B, Abedin B, Vakili-Zarch A, Meysamie A-P, Yazdanpanah F (2011) Bone mineral density and coronary atherosclerosis. J Saudi Heart Assoc 23(3):143–146CrossRef
23.
go back to reference Iranpour D, Pourbehi M, Afroozandeh M, Davoodi N, Bidel-Khoshbakht S, Nabipour I, Javadi H, Seyedabad M, Assadi M (2014) Bone mineral density is not related to angiographically diagnosed coronary artery disease. Hell J Nucl Med Iranpour D, Pourbehi M, Afroozandeh M, Davoodi N, Bidel-Khoshbakht S, Nabipour I, Javadi H, Seyedabad M, Assadi M (2014) Bone mineral density is not related to angiographically diagnosed coronary artery disease. Hell J Nucl Med
24.
go back to reference Alissa EM, Alnahdi WA, Alama N, Ferns GA (2015) Bone mineral density and cardiovascular risk factors in postmenopausal women with coronary artery disease. BoneKEy reports 4 Alissa EM, Alnahdi WA, Alama N, Ferns GA (2015) Bone mineral density and cardiovascular risk factors in postmenopausal women with coronary artery disease. BoneKEy reports 4
25.
go back to reference Liu N, Chen J, Zhang K, Tang Z (2016) A community-based study of the relationship between coronary artery disease and osteoporosis in Chinese postmenopausal women. Coron Artery Dis 27(1):59–64CrossRef Liu N, Chen J, Zhang K, Tang Z (2016) A community-based study of the relationship between coronary artery disease and osteoporosis in Chinese postmenopausal women. Coron Artery Dis 27(1):59–64CrossRef
26.
go back to reference Alan B, Akpolat V, Aktan A, Alan S (2016) Relationship between osteopenic syndrome and severity of coronary artery disease detected with coronary angiography and Gensini score in men. Clin Interv Aging 11:377CrossRef Alan B, Akpolat V, Aktan A, Alan S (2016) Relationship between osteopenic syndrome and severity of coronary artery disease detected with coronary angiography and Gensini score in men. Clin Interv Aging 11:377CrossRef
27.
go back to reference Guan X-q, Xue Y-j, Wang J, Ma J, Li Y-c, Zheng C, Wu S-z (2018) low bone mineral density is associated with global coronary atherosclerotic plaque burden in stable angina patients. Clin Interv Aging 13:1475CrossRef Guan X-q, Xue Y-j, Wang J, Ma J, Li Y-c, Zheng C, Wu S-z (2018) low bone mineral density is associated with global coronary atherosclerotic plaque burden in stable angina patients. Clin Interv Aging 13:1475CrossRef
28.
go back to reference Samelson EJ, Kiel DP, Broe KE, Zhang Y, Cupples LA, Hannan MT, Wilson PW, Levy D, Williams SA, Vaccarino V (2004) Metacarpal cortical area and risk of coronary heart disease: the Framingham study. Am J Epidemiol 159(6):589–595CrossRef Samelson EJ, Kiel DP, Broe KE, Zhang Y, Cupples LA, Hannan MT, Wilson PW, Levy D, Williams SA, Vaccarino V (2004) Metacarpal cortical area and risk of coronary heart disease: the Framingham study. Am J Epidemiol 159(6):589–595CrossRef
29.
go back to reference Veronese N, Stubbs B, Crepaldi G, Solmi M, Cooper C, Harvey NC, Reginster JY, Rizzoli R, Civitelli R, Schofield P (2017) Relationship between low bone mineral density and fractures with incident cardiovascular disease: a systematic review and meta-analysis. J Bone Miner Res 32(5):1126–1135CrossRef Veronese N, Stubbs B, Crepaldi G, Solmi M, Cooper C, Harvey NC, Reginster JY, Rizzoli R, Civitelli R, Schofield P (2017) Relationship between low bone mineral density and fractures with incident cardiovascular disease: a systematic review and meta-analysis. J Bone Miner Res 32(5):1126–1135CrossRef
30.
go back to reference Wu M, Rementer C, Giachelli CM (2013) Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int 93(4):365–373CrossRef Wu M, Rementer C, Giachelli CM (2013) Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int 93(4):365–373CrossRef
31.
go back to reference Doherty TM, Asotra K, Fitzpatrick LA, Qiao J-H, Wilkin DJ, Detrano RC, Dunstan CR, Shah PK, Rajavashisth TB (2003) Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci 100(20):11201–11206CrossRef Doherty TM, Asotra K, Fitzpatrick LA, Qiao J-H, Wilkin DJ, Detrano RC, Dunstan CR, Shah PK, Rajavashisth TB (2003) Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci 100(20):11201–11206CrossRef
32.
go back to reference Persy V, D’Haese P (2009) Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 15(9):405–416CrossRef Persy V, D’Haese P (2009) Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 15(9):405–416CrossRef
33.
go back to reference Mao P-J, Zhang C, Tang L, Xian Y-Q, Li Y-S, Wang W-D, Zhu X-H, Qiu H-L, He J, Zhou Y-H (2013) Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol 169(2):106–111CrossRef Mao P-J, Zhang C, Tang L, Xian Y-Q, Li Y-S, Wang W-D, Zhu X-H, Qiu H-L, He J, Zhou Y-H (2013) Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol 169(2):106–111CrossRef
34.
go back to reference Lewis JR, Radavelli-Bagatini S, Rejnmark L, Chen JS, Simpson JM, Lappe JM, Mosekilde L, Prentice RL, Prince RL (2015) The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res 30(1):165–175CrossRef Lewis JR, Radavelli-Bagatini S, Rejnmark L, Chen JS, Simpson JM, Lappe JM, Mosekilde L, Prentice RL, Prince RL (2015) The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res 30(1):165–175CrossRef
35.
go back to reference An T, Hao J, Sun S, Li R, Yang M, Cheng G, Zou M (2017) Efficacy of statins for osteoporosis: a systematic review and meta-analysis. Osteoporos Int 28(1):47–57CrossRef An T, Hao J, Sun S, Li R, Yang M, Cheng G, Zou M (2017) Efficacy of statins for osteoporosis: a systematic review and meta-analysis. Osteoporos Int 28(1):47–57CrossRef
36.
go back to reference Liu J, Zhu L-P, Yang X-L, Huang H-L, Ye D-Q (2013) HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis. Bone 54(1):151–156CrossRef Liu J, Zhu L-P, Yang X-L, Huang H-L, Ye D-Q (2013) HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis. Bone 54(1):151–156CrossRef
37.
go back to reference Yue J, Zhang X, Dong B, Yang M (2010) Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials. Menopause 17(5):1071–1079CrossRef Yue J, Zhang X, Dong B, Yang M (2010) Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials. Menopause 17(5):1071–1079CrossRef
38.
go back to reference Peterson RA, Brown SP (2005) On the use of beta coefficients in meta-analysis. J Appl Psychol 90(1):175–181CrossRef Peterson RA, Brown SP (2005) On the use of beta coefficients in meta-analysis. J Appl Psychol 90(1):175–181CrossRef
39.
go back to reference Rajzbaum G, Bézie Y (2006) Postmenopausal osteoporosis and atheroma. Joint Bone Spine 73(6):661–666CrossRef Rajzbaum G, Bézie Y (2006) Postmenopausal osteoporosis and atheroma. Joint Bone Spine 73(6):661–666CrossRef
Metadata
Title
Associations between bone mineral density and coronary artery disease: a meta-analysis of cross-sectional studies
Authors
Yonghui Zhang
Bing He
Haijiao Wang
Jianwei Shi
Hao Liang
Publication date
01-12-2020
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2020
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-020-0691-1

Other articles of this Issue 1/2020

Archives of Osteoporosis 1/2020 Go to the issue